Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
NKGN - NKGen Biotech Inc - Stock Price Chart
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap38.46MEPS (ttm)-4.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-989.64%
Dividend-Sales Q/Q-
Insider Own58.03%Inst Own8.08%
Insider Trans0.01%Inst Trans14.32%
Short Float5.83%Earnings-
Analyst Recom-Target Price-
Avg Volume4.13M52W Range0.78 - 12.88
May-20-24 11:41AM NKGN Stock Alert: The Alzheimer's News That Has NKGen Biotech Soaring Today (InvestorPlace) +52.68%
08:05AM NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease (GlobeNewswire)
May-16-24 08:05AM NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition (GlobeNewswire)
Apr-29-24 08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinsons Disease (GlobeNewswire)
Apr-25-24 04:05PM NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) +15.79%
Apr-24-24 04:45PM NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -7.57%
Apr-18-24 04:05PM NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) -16.50%
Apr-16-24 11:53PM NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 08:05AM NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs (GlobeNewswire)
Mar-25-24 04:05PM NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer's Disease at the Tau2024 Global Conference (GlobeNewswire) -6.90%
SMN - ProShares UltraShort Materials - Stock Price Chart
TickerSMN [NYSE]
CompanyProShares UltraShort Materials
CountryUSA
IndustryExchange Traded Fund
CategoryEquity - Leveraged / Inverse
IndexS&P Materials Select Sector Index
TagsU.S., equity, materials, SP500, leverage, inverse
Sector/Theme Region
Dividend5.43%Active/Passive
Total Holdings8AUM960.89K
Flows% 1M0.00%Flows% 3M-17.26%
Flows% YTD-17.15%Flows% 1Y
Return% 1Y-25.27%Return% 3Y-0.16%
Return% 5Y-33.89%Return% 10Y
NAV% Expense
Avg Volume4.13K52W Range6.85 - 11.08
PEGY - Pineapple Energy Inc - Stock Price Chart
TickerPEGY [NASD]
CompanyPineapple Energy Inc
CountryUSA
IndustrySolar
Market Cap18.23MEPS (ttm)-0.81
P/E-EPS this Y-10.14%
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.94%
P/S0.26EPS next 5Y-
P/B-EPS Q/Q0.31%
Dividend-Sales Q/Q-40.09%
Insider Own4.27%Inst Own9.82%
Insider Trans-4.38%Inst Trans1.79%
Short Float6.97%EarningsMay 09/a
Analyst Recom3.00Target Price0.10
Avg Volume45.98M52W Range0.04 - 1.53
IBTX - Independent Bank Group Inc - Stock Price Chart
TickerIBTX [NASD, RUT]
CompanyIndependent Bank Group Inc
CountryUSA
IndustryBanks - Regional
Market Cap1.96BEPS (ttm)1.95
P/E24.25EPS this Y-19.59%
Forward P/E12.03EPS next Y48.64%
PEG2.43EPS past 5Y-24.76%
P/S2.04EPS next 5Y10.00%
P/B0.82EPS Q/Q100.07%
Dividend3.23%Sales Q/Q16.96%
Insider Own13.45%Inst Own79.47%
Insider Trans0.00%Inst Trans-2.23%
Short Float6.64%EarningsApr 22/a
Analyst Recom2.29Target Price46.57
Avg Volume241.47K52W Range32.75 - 53.25
DXF - Dunxin Financial Holdings Limited. ADR - Stock Price Chart
TickerDXF [AMEX]
CompanyDunxin Financial Holdings Limited. ADR
CountryChina
IndustryCredit Services
Market Cap6.91MEPS (ttm)-9.89
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.82EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q114.09%
Insider Own-Inst Own0.49%
Insider Trans-Inst Trans-
Short Float0.60%Earnings-
Analyst Recom-Target Price-
Avg Volume537.26K52W Range0.18 - 2.90
PLAO - Patria Latin American Opportunity Acquisition Corp - Stock Price Chart
TickerPLAO [NASD]
CompanyPatria Latin American Opportunity Acquisition Corp
CountryCayman Islands
IndustryShell Companies
Market Cap258.21MEPS (ttm)0.40
P/E28.31EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.42EPS Q/Q-20.81%
Dividend-Sales Q/Q-
Insider Own27.18%Inst Own70.39%
Insider Trans0.00%Inst Trans14.20%
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume60.40K52W Range10.62 - 11.97
AVEE - Avantis Emerging Markets Small Cap Equity ETF - Stock Price Chart
TickerAVEE [NYSE]
CompanyAvantis Emerging Markets Small Cap Equity ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Factor & Thematic
Index-
TagsEmerging, equity, small-cap
Sector/Theme Region
Dividend0.37%Active/Passive
Total Holdings1514AUM14.18M
Flows% 1M0.00%Flows% 3M59.61%
Flows% YTD59.61%Flows% 1Y
Return% 1Y-Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume2.85K52W Range49.81 - 56.99
ZENV - Zenvia Inc - Stock Price Chart
TickerZENV [NASD]
CompanyZenvia Inc
CountryBrazil
IndustrySoftware - Application
Market Cap161.24MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.00EPS next 5Y-
P/B0.88EPS Q/Q79.63%
Dividend-Sales Q/Q31.60%
Insider Own97.28%Inst Own9.21%
Insider Trans0.00%Inst Trans-4.38%
Short Float5.67%EarningsApr 30/a
Analyst Recom3.00Target Price1.80
Avg Volume76.77K52W Range0.65 - 3.88
SER - Serina Therapeutics Inc. - Stock Price Chart
TickerSER [AMEX]
CompanySerina Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap84.10MEPS (ttm)-13.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-12.67%
P/S600.71EPS next 5Y-
P/B1.97EPS Q/Q-27.85%
Dividend-Sales Q/Q600.00%
Insider Own86.04%Inst Own1.38%
Insider Trans0.00%Inst Trans-3.08%
Short Float0.35%Earnings-
Analyst Recom-Target Price-
Avg Volume8.95K52W Range7.86 - 35.17
GRI - GRI Bio Inc - Stock Price Chart
TickerGRI [NASD]
CompanyGRI Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap1.62MEPS (ttm)-26.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y26.64%
P/S-EPS next 5Y-
P/B0.49EPS Q/Q98.77%
Dividend-Sales Q/Q-
Insider Own1.50%Inst Own6.21%
Insider Trans0.00%Inst Trans6.63%
Short Float0.44%EarningsApr 01/b
Analyst Recom1.00Target Price2520.00
Avg Volume333.57K52W Range0.38 - 49.28
123456789101120